My child has two ATP7B mutations but no symptoms — does she need treatment now?

Finding out that your toddler carries two copies of an ATP7B mutation — meaning she has Wilson disease even though she seems completely well — is a frightening kind of news. You are facing a diagnosis for a child who looks healthy, and you are being asked to consider putting her on medication that she will likely need for the rest of her life. That is a lot to process.

The reassuring part: this is exactly the situation where early treatment works best. A child found this way — before the liver or brain has been damaged — has an excellent long-term prognosis with appropriate care.¹ The harder part: waiting to see symptoms develop is not safe, because copper accumulates silently for years before damage becomes visible.

Why presymptomatic treatment matters

Wilson disease does not cause damage the moment copper starts building up. Instead, copper accumulates gradually in the liver over years — sometimes decades — before symptoms appear.² By the time a child has an elevated liver enzyme, significant hepatic copper loading has already occurred. By the time neurological symptoms develop, the window for easy reversal has often passed.

The reason your daughter was tested in the first place was almost certainly because a family member — a sibling, parent, or cousin — was diagnosed with Wilson disease, triggering genetic screening of relatives. That screening process exists specifically to catch this situation: a child who has the disease but has not yet been harmed by it.³

Starting treatment now is not aggressive medicine. It is the most defensible approach given what we know.

What treatment looks like for a presymptomatic two-year-old

The preferred treatment for presymptomatic children, and for young patients with minimal disease burden, is zinc.¹⁴ Zinc works by inducing metallothionein in intestinal cells, which binds copper and prevents it from being absorbed. It does not remove copper that is already stored, but at age two, very little should be stored yet. The goal is simply to stop more copper from accumulating.

Zinc salts are available in several forms (zinc acetate, zinc sulfate, zinc gluconate). The dose is adjusted for body weight and will change as your daughter grows — this is something her specialist will monitor. The most common side effect is stomach irritation, particularly when the first dose is taken in the morning without food. Many families find that a small amount of protein (like a spoonful of peanut butter) taken alongside the morning dose reduces this. It is worth discussing with her doctor what formulation and timing work best.

Chelating agents (penicillamine or trientine) are generally reserved for children who already have significant liver disease or who are symptomatic. They carry more side-effect risk and are more potent than what a presymptomatic child typically needs.⁵

What monitoring looks like

Starting treatment is only the beginning. Your daughter will need regular monitoring, likely every three to six months initially, with less frequent check-ins once she is stable. Typical monitoring includes:

• Liver function tests (ALT, AST, bilirubin) — to detect any liver inflammation
• Serum ceruloplasmin — a copper-transport protein that is low in Wilson disease
• 24-hour urinary copper excretion — the most useful indicator of whether copper is being controlled
• Zinc levels — to make sure she is getting enough but not too much

As she gets older, periodic eye examinations for Kayser-Fleischer rings may also be done, although rings are rarely present in young children before significant copper loading occurs.²

The monitoring schedule and what constitutes a good response will be individualized to her. What your team is watching for is stability: liver tests staying normal, urinary copper well controlled, and no new symptoms developing.

What about her diet?

At age two, strict dietary copper restriction is not recommended as a substitute for medication, though it makes sense to avoid the very highest copper foods — shellfish (especially oysters), liver, and chocolate in large amounts — as a sensible background habit.⁶ The medication is what does the real work. Trying to manage Wilson disease through diet alone is not effective and is not recommended by any major guideline.¹

See diet-and-copper for more detail on which foods are highest in copper and what the practical guidance looks like for families.

Will she always need treatment?

Yes. Wilson disease is a lifelong condition. The mutation does not change, and without ongoing treatment, copper will start accumulating again. However, many patients on zinc therapy live entirely normal lives — normal development, normal schooling, normal activity. The medication is a daily routine, not a limitation on what she can do or who she can become.

As she grows, the conversation will evolve. Zinc dosing changes with weight and age. Adolescence sometimes brings adherence challenges — this is worth discussing with her care team before it becomes an issue. See kids-school for practical guidance on managing Wilson disease in childhood and school settings, including how to think about disclosure and self-management as children get older.

One thing to watch for: misdiagnosis or testing ambiguity

A two-year-old carrying two pathogenic ATP7B variants has confirmed Wilson disease. However, the genetics of Wilson disease are complex — there are hundreds of known pathogenic variants, and the significance of some variants is uncertain. If there was any ambiguity in how the genetic result was reported (for example, if one variant is “likely pathogenic” rather than definitively pathogenic), it is worth asking your specialist to clarify. A liver biopsy with copper quantification can confirm the diagnosis independently of genetic testing if there is genuine doubt.³

Most commonly, though, if your daughter tested positive for two known pathogenic variants through a reputable laboratory, the diagnosis is solid.

This article is for patient education and information purposes only. Treatment decisions for a presymptomatic child should be made with a pediatric hepatologist or a specialist in metabolic liver disease who can review her specific results and monitor her care over time.

References